Our Process: From Concept to Shelf

Our Process: From Concept to Shelf

Your OEM, Private Label & White Label Journey

Building a beauty brand should feel clear, not complicated. At Global Beauty Products, we guide you through a controlled process from your first brief to finished, market-ready products - covering product choice, packaging, artwork, manufacturing, quality control and the regulatory information needed for your target market.

Two Routes, One Controlled Journey

 Private Label / White Label

Bespoke OEM Development

Choose from established Global Beauty Products formulations and packaging options, then customise the product with your brand. This is normally the quickest route to market.

If you need a new or materially changed formulation, the project includes additional development, samples, testing, safety assessment and approval stages before bulk production.


Step 1

To begin, you must contact our sales team at info@gbp.ltd with your concept, intended sales markets and the products you are interested in. Knowing where you plan to sell is important from the start because the Responsible Person, notification/listing and labelling route must be agreed upon before artwork is approved.

 

Step 2

Together we agree on the product or formula route, format, size, quantity, packaging, colours and other specifications. For private-label products, this is where you select from established options. Bespoke OEM projects move through additional formulation, sample and testing stages before the specification is locked.

 

Step 3

Once the specification is clear, we issue a quotation setting out the agreed products, quantities, and relevant packaging, printing, tooling, design, or regulatory service charges. For international orders, final carriage may be confirmed once the shipment is packed and the actual shipping dimensions and weight are known.

 

Step 4

When you are happy with the quotation, you confirm the order and pay the agreed 50% deposit. This activates purchasing, artwork and production planning. No bulk production starts until the required commercial and technical approvals are in place.

 

Step 5

Our in-house design team prepares your product artwork or checks the artwork you supply. Before print approval, the label is reviewed against the agreed market requirements, including the correct Responsible Person or US responsible-person details, product function, content, batch/traceability information, precautions, and ingredient information, where applicable. Nothing is sent to print until you provide written artwork approval.

 

Step 6

Once approvals are complete, we manufacture and pack your products under GMP-controlled procedures, with batch traceability and quality checks. Global Beauty Products holds and maintains the confidential manufacturing and technical evidence for the agreed compliance route. Where we provide our Responsible Person / regulatory-custodian service, we complete the applicable UK/EU notification on your behalf and deal directly with the competent authority where legally required. For the USA, we support the agreed MoCRA facility, product-listing and technical-information route; the US responsible person and any required US agent are agreed separately.

 

Step 7

When the goods are completed, packed and ready for release, the remaining 50% balance becomes due. Once payment and any final carriage arrangements are complete, the order is dispatched. Your product must not be placed on the target market until the applicable regulatory steps for that market have been completed.

Regulatory overview

The regulatory route is determined by where you intend to sell. The following is the core position for cosmetics in Great Britain, the European Union and the United States:

Our anonymous Responsible Person service

For Great Britain and EU markets, where agreed, Global Beauty Products can provide an anonymous Responsible Person and regulatory-document-custodian service through the appropriate Global Beauty Products entity. This follows our established private-label model: Global Beauty Products holds the confidential PIF and underlying formulation/manufacturing evidence, completes the applicable SCPN or CPNP notification on the customer's behalf, maintains the regulatory file, and responds directly and digitally to competent authorities when legally required. The customer is routinely supplied with the accurate INCI and SDS; CPSR Part B can also be supplied, showing the safety conclusion and assessor credentials. We do not release the confidential bulk formula, manufacturing data or full technical pack through the customer's supply chain unless disclosure is legally required. Where an authority lawfully requires further information, Global Beauty Products provides it directly to that authority.

What "anonymous” means: the confidential manufacturing source and technical pack are protected; it does not remove any Responsible Person name/address or other information that the law requires to appear on the product label.

Market

Before the Product is Placed on the Market

Key Market Step

Great Britain A UK-established Responsible Person, safety assessment/CPSR, Product Information File (PIF), GMP-compliant manufacture and compliant labelling. The Responsible Person notifies OPSS through the Submit Cosmetic Product Notifications (SCPN) service before the product is made available in GB.
European Union An EU-established Responsible Person, safety assessment/CPSR, Product Information File (PIF), GMP-compliant manufacture and compliant labelling. The Responsible Person completes notification through the EU Cosmetic Products Notification Portal (CPNP) before the product is placed on the EU market.
United States MoCRA applies alongside the Federal Food, Drug, and Cosmetic Act and the US cosmetic-labelling rules. A foreign manufacturing facility that is required to register must register with the FDA, renew biannually, and appoint a US agent. The responsible person whose name appears on the label must maintain adequate safety substantiation, and the product must be correctly labelled. The responsible person lists each marketed cosmetic product with the FDA, including ingredients, and updates the listing annually. Serious adverse events must be reported to the FDA within 15 business days. Global Beauty Products provides the manufacturing and ingredient information required for the agreed-upon filing route and can communicate confidential technical information directly to the FDA when legally required.
Other Markets Requirements vary by country and product type. Tell us your intended markets at the start so the project can be scoped correctly, and any additional documentation, testing or registration can be identified early.


What we need from you

  • Your product brief and intended target market(s).
  • Your chosen products, quantities, packaging and any customisation requirements.
  • Brand assets and artwork information, or approval for Global Beauty Products to create the artwork.
  • Prompt written approval of quotations, product specifications and final artwork.
  • The agreed deposit and final balance at the relevant stages.
  • Confirmation of the regulatory arrangement for each market - including the UK/EU Responsible Person route and, for the USA, the responsible person named on the label and any required US agent.

 

READY TO START?

Your Brand. Our Expertise.

Please browse our catalogue and contact our team at info@gbp.ltd to start your beauty journey.